BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23971743)

  • 1. The biosynthesis and biological function of diphthamide.
    Su X; Lin Z; Lin H
    Crit Rev Biochem Mol Biol; 2013; 48(6):515-21. PubMed ID: 23971743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous ADP-ribosylation of elongation factor-2 by interleukin-1β.
    Jäger D; Werdan K; Müller-Werdan U
    Mol Cell Biochem; 2011 Feb; 348(1-2):125-8. PubMed ID: 21088871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A.
    Zhang Y; Liu S; Lajoie G; Merrill AR
    Biochem J; 2008 Jul; 413(1):163-74. PubMed ID: 18373493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dominant-negative approach that prevents diphthamide formation confers resistance to Pseudomonas exotoxin A and diphtheria toxin.
    Roy V; Ghani K; Caruso M
    PLoS One; 2010 Dec; 5(12):e15753. PubMed ID: 21203470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
    Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
    Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral insertional mutagenesis identifies a small protein required for synthesis of diphthamide, the target of bacterial ADP-ribosylating toxins.
    Liu S; Leppla SH
    Mol Cell; 2003 Sep; 12(3):603-13. PubMed ID: 14527407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly frequent single amino acid substitution in mammalian elongation factor 2 (EF-2) results in expression of resistance to EF-2-ADP-ribosylating toxins.
    Kohno K; Uchida T
    J Biol Chem; 1987 Sep; 262(25):12298-305. PubMed ID: 2887567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploid genetic screens in human cells identify host factors used by pathogens.
    Carette JE; Guimaraes CP; Varadarajan M; Park AS; Wuethrich I; Godarova A; Kotecki M; Cochran BH; Spooner E; Ploegh HL; Brummelkamp TR
    Science; 2009 Nov; 326(5957):1231-5. PubMed ID: 19965467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the elongation factor 2 gene which confer resistance to diphtheria toxin and Pseudomonas exotoxin A. Genetic and biochemical analyses.
    Foley BT; Moehring JM; Moehring TJ
    J Biol Chem; 1995 Sep; 270(39):23218-25. PubMed ID: 7559470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
    Oppenheimer NJ; Bodley JW
    J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H; Iglewski WJ
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADPRibosylating Toxins.
    Mayer K; Schröder A; Schnitger J; Stahl S; Brinkmann U
    Toxins (Basel); 2017 Feb; 9(3):. PubMed ID: 28245596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stealth and mimicry by deadly bacterial toxins.
    Yates SP; Jørgensen R; Andersen GR; Merrill AR
    Trends Biochem Sci; 2006 Feb; 31(2):123-33. PubMed ID: 16406634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor.
    Stahl S; da Silva Mateus Seidl AR; Ducret A; Kux van Geijtenbeek S; Michel S; Racek T; Birzele F; Haas AK; Rueger R; Gerg M; Niederfellner G; Pastan I; Brinkmann U
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10732-7. PubMed ID: 26261303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family.
    Lugo MR; Merrill AR
    Toxins (Basel); 2015 Jul; 7(8):2757-72. PubMed ID: 26213968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diphthamide modification pathway from Saccharomyces cerevisiae--revisited.
    Schaffrath R; Abdel-Fattah W; Klassen R; Stark MJ
    Mol Microbiol; 2014 Dec; 94(6):1213-26. PubMed ID: 25352115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in codon 717 of the CHO-K1 elongation factor 2 gene prevents the first step in the biosynthesis of diphthamide.
    Foley BT; Moehring JM; Moehring TJ
    Somat Cell Mol Genet; 1992 May; 18(3):227-31. PubMed ID: 1353910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro biosynthesis of diphthamide, studied with mutant Chinese hamster ovary cells resistant to diphtheria toxin.
    Moehring TJ; Danley DE; Moehring JM
    Mol Cell Biol; 1984 Apr; 4(4):642-50. PubMed ID: 6717439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific mutagenesis of the histidine precursor of diphthamide in the human elongation factor-2 gene confers resistance to diphtheria toxin.
    Ivankovic M; Rubelj I; Matulic M; Reich E; Brdar B
    Mutat Res; 2006 Oct; 609(1):34-42. PubMed ID: 16901746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccharomyces cerevisiae elongation factor 2. Mutagenesis of the histidine precursor of diphthamide yields a functional protein that is resistant to diphtheria toxin.
    Phan LD; Perentesis JP; Bodley JW
    J Biol Chem; 1993 Apr; 268(12):8665-8. PubMed ID: 8473309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.